KleinEColinVStolkJLenoxRH. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: Vulnerability and effect of carbemazepine. Am J Psychiatry1994;151:1760–6.
2.
JuergensSM. Benzodiazepines, other sedative, hypnotic, and anxiolytic drugs, and addiction. In: MillerNS, editor. The principles and practice of addictions in psychiatry. Philadelphia (PA): WB Saunders Company; 1997.
3.
McNamaraJ.Drugs effective in the therapy of the epilepsies. In: GilmanAGRallTW, editors. Goodman and Gilman's the pharmacologic basis of therapeutics. 9th ed.New York: Pergamon; 1996.
4.
MaoJChenLL. Gabapentin in pain management. Anesth Analg2000;91:680–7.
5.
PandeACDavidsonJRTJeffersonJWJanneyCAKatzelnickDJWeislerRH, and others. Treatment of social phobia with gabapentin: A placebo-controlled study. J Clin Psychopharmacol1999;19:341–8.
6.
ChouinardGBeauclairLBelangerMC. Gabapentin: Long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders [letter]. Can J Psychiatry1998;43:305.
7.
BrannonNLabbateLHuberM.Gabapentin treatment for posttraumatic stress disorder [letter]. Can J Psychiatry2000;45:84.
8.
ChatterjeeCRRingoldAL. A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin [letter]. J Clin Psychiatry1999;60:617.
9.
RickelsKCaseWGSchweizerEGarcia-EspanaFFridmanR.Long-term benzodiazepine users 3 years after participation in a discontinuation program. Am J Psychiatry1991;148:757–61.
